Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases

NCT04463368 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

OTHER_GOV

Sponsor class

Conditions

Uveal Melanoma
Liver Metastases

Interventions

PROCEDURE: Isolated hepatic perfusion
DRUG: Ipilimumab
DRUG: Nivolumab

Sponsor

Vastra Gotaland Region

Collaborators

[object Object]